Your session is about to expire
← Back to Search
Personalized Medication Management for Multiple Medications Safety
Study Summary
This trial seeks to see if a personalized clinic can help lower risk of side effects & improve prescribing decisions when taking multiple medications. Doctors will look for variations in genes to suggest risk of side effects or chance of benefiting from meds. Trial length: 9 months.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am being considered for or have had a liver or kidney transplant.I am taking 5 or more medications, including one that requires genetic testing.I am able to understand and agree to participate in the study.I am 18 years old or older.
- Group 1: Group 1: Prescribing Based on Information From Both Drug-Drug and Drug-Gene Profiles
- Group 2: Group 2: Prescribing Based ONLY on Information From Drug-Drug Interaction Profiles
- Group 3: Group 3: Prescribing Not Based on ANY Profile Information (Drug-Drug or Drug-Gene Interactions)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have been enrolled in this research initiative?
"Affirmative. According to clinicaltrials.gov, this medical experiment has opened for recruitment and is actively seeking participants since November 30th 2022. The trial needs 1300 patients from 1 site to be enrolled in it before the most recent update of December 6th 2022."
Are there any vacancies available to participants in this clinical trial?
"Affirmative. Information posted to clinicaltrials.gov indicates that this medical trial, first shared on November 30th 2022 and most recently edited on December 6th 2022, is actively recruiting. The research team requires 1300 participants from a single site for the study."
Share this study with friends
Copy Link
Messenger